Diagnos Inc.
DGNOF
$0.189
-$0.0047-2.43%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 9.38% | -31.18% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 9.38% | -31.18% | |||
| Cost of Revenue | 31.66% | 0.14% | |||
| Gross Profit | -33.07% | -3.11% | |||
| SG&A Expenses | -31.60% | 23.75% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -16.76% | 17.26% | |||
| Operating Income | 17.13% | -18.44% | |||
| Income Before Tax | 13.65% | -7.51% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 13.65% | -7.51% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 13.65% | -7.51% | |||
| EBIT | 17.13% | -18.44% | |||
| EBITDA | 19.54% | -21.79% | |||
| EPS Basic | 15.96% | -2.17% | |||
| Normalized Basic EPS | 16.95% | -1.72% | |||
| EPS Diluted | 15.96% | -2.17% | |||
| Normalized Diluted EPS | 16.95% | -1.72% | |||
| Average Basic Shares Outstanding | 2.91% | 5.60% | |||
| Average Diluted Shares Outstanding | 2.91% | 5.60% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||